Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity

Clinical and Vaccine Immunology

Volumn 15, Issue 7, 2008, Pages 1054-1059

  Haralambieva, Iana H ^a   Ovsyannikova, Inna G ^a   Vierkant, Robert A ^b   Poland, Gregory A ^a,b  

^a Mayo Vaccine Research Group   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G; MEASLES VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE; HUMAN; HUMORAL IMMUNITY; IMMUNOASSAY; MALE; MEASLES; MEASLES VIRUS; NORMAL HUMAN; PLAQUE REDUCTION MICRONEUTRALIZATION ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS RECOMBINANT;

ADOLESCENT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MEASLES; MEASLES VIRUS; NEUTRALIZATION TESTS; PLAQUE ASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 47649086130     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00008-08     Document Type: Article

References (20)

1. Albrecht, P., K. Herrmann, and G. R. Burns. 1981. Role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3:251-260.
2. Ballew, H. C. 1992. Neutralization, p. 229-241. In S. Specter and G. Lancz (ed.), Clinical virology manual. Elsevier, New York, NY.
3. Bouche, F., W. Ammerlaan, F. Berthet, S. Houard, F. Schneider, and C. P. Muller. 1998. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity. J. Clin. Microbiol. 36:721-726.
4. Bouche, F. B., O. T. Ertl, and C. P. Muller. 2002. Neutralizing B cell response in measles. Viral Immunol. 15:451-471.
5. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
6. Cohen, B. J., R. P. Parry, D. Doblas, D. Samuel, L. Warrener, N. Andrews, and D. Brown. 2006. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J. Virol. Methods 131:209-212.
7. Cohen, B. J., S. Audet, N. Andrews, and J. Beeler. 2007. Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26:59-66.
8. Dhiman, N., G. A. Poland, J. M. Cunningham, R. M. Jacobson, I. G. Ovsyannikova, R. A. Vierkant, Y. Wu, and V. S. Pankratz. 2007. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J. Allergy Clin. Immunol. 201:666-672.
9. Duprex, W. P., S. McQuaid, L. Hangartner, M. A. Billeter, and B. K. Rima. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73:9568-9575.
10. Fujino, M., N. Yoshida, K. Kimura, J. Zhou, Y. Motegi, K. Komase, and T. Nakayama. 2007. Development of a new neutralization test for measles virus. J. Virol. Methods 142:15-20.
11. Goncalves, G., F. Cutts, T. Forsey, and H. R. Andrade. 1999. Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement. Rev. Inst. Med. Trop. Sao Paulo 41:21-26.
12. Hesketh, L., A. Charlett, P. Farrington, E. Miller, T. Forsey, and P. Morgan-Capner. 1997. An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J. Virol. Methods 66:51-59.
13. Lee, M. S., B. Cohen, J. Hand, and D. J. Nokes. 1999. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody. J. Virol. Methods 78:209-217.
14. Manischewitz, J., L. R. King, N. A. Bleckwenn, J. Shiloach, R. Taffs, M. Merchlinsky, N. Eller, M. G. Mokplajczyk, D. J. Clanton, T. Monath, R. A. Weltzin, D. E. Scott, and H. Golding. 2003. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J. Infect. Dis. 188:440-448.
15. Moss, W. J., and D. E. Griffin. 2006. Global measles elimination. Nat. Rev. Microbiol. 4:900-908.
16. Ovsyannikova, I. G., R. M. Jacobson, R. A. Vierkant, S. J. Jacobsen, V. S. Pankratz, and G. A. Poland. 2004. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum. Immunol. 65:1506-1515.
17. Poland, G. A., and R. M. Jacobson. 1994. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Arch. Intern. Med. 154:1815-1820.
18. Ratnam, S., V. Gadag, R. West, J. Burris, E. Oates, F. Stead, and N. Boulianne. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J. Clin. Microbiol. 33:811-815.
19. Vongpunsawad, S., N. Oezgun, W. Braun, and R. Cattaneo. 2004. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J. Virol. 78:302-313.
20. Ward, B. J., S. Aouchiche, N. Martel, F. M. Bertley, N. Bautista-Lopez, B. Serhir, and S. Ratnam. 1999. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagn. Microbiol. Infect. Dis. 33:147-152.